Skip to main content
eScholarship
Open Access Publications from the University of California
Refine Search

UC Irvine

UC Irvine Previously Published Works bannerUC Irvine

Phase 1, multicenter, open-label, dose-escalation, study of marizomib (MRZ) and bevacizumab (BEV) in WHO grade IV malignant glioma (G4 MG).

Published Web Location

https://doi.org/10.1200/jco.2016.34.15_suppl.2037Creative Commons 'BY' version 4.0 license
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View


Top